Inventor
FESIK STEPHEN W
US31 patents
⚠️ This page may combine multiple inventors who share the name “FESIK STEPHEN W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV VANDERBILT
18 patentsUS10533010B2Jan 14, 2020
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT3 citations71
US10501466B2Dec 10, 2019
WDR5 inhibitors and modulators
UNIV VANDERBILT3 citations71
US10160763B2Dec 25, 2018
WDR5 inhibitors and modulators
UNIV VANDERBILT5 citations71
US10844044B2Nov 24, 2020
WDR5 inhibitors and modulators
UNIV VANDERBILT4 citations69
US10954193B2Mar 23, 2021
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations61
US12195472B2Jan 14, 2025
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations60
US11208415B2Dec 28, 2021
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations60
US12144816B2Nov 19, 2024
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations59
US11596639B2Mar 7, 2023
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT1 citations59
US10807959B2Oct 20, 2020
WDR5-MLL1 inhibitors and modulators
UNIV VANDERBILT2 citations59
US11999716B2Jun 4, 2024
WDR5 inhibitors and modulators
UNIV VANDERBILT1 citations58
US10005728B2Jun 26, 2018
Substituted indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations50
US10844032B2Nov 24, 2020
Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitors
UNIV VANDERBILT0 citations49
US10093640B2Oct 9, 2018
Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors
UNIV VANDERBILT0 citations49
US12577227B2Mar 17, 2026
WDR5 inhibitors and modulators
UNIV VANDERBILT0 citations46
US12398097B2Aug 26, 2025
WDR5-MYC inhibitors
UNIV VANDERBILT0 citations45
US11318137B2May 3, 2022
Quinazoline compounds as modulators of Ras signaling
UNIV VANDERBILT0 citations44
US9949965B2Apr 24, 2018
Tricyclic indole Mcl-1 inhibitors and uses thereof
UNIV VANDERBILT0 citations40
ABBOTT LAB
12 patentsUS7504512B2Mar 17, 2009
N-acylsulfonamide apoptosis promoters
ABBOTT LAB58 citations97
US6720338B2Apr 13, 2004
N-acylsulfonamide apoptosis promoters
ABBOTT LAB98 citations97
US5891643AApr 6, 1999
Use of nuclear magnetic resonance to design ligands to target biomolecules
ABBOTT LAB67 citations95
US5804390ASep 8, 1998
Use of nuclear magnetic resonance to identify ligands to target biomolecules
ABBOTT LAB70 citations95
US5698401ADec 16, 1997
Use of nuclear magnetic resonance to identify ligands to target biomolecules
ABBOTT LAB82 citations95
US6043024AMar 28, 2000
Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
ABBOTT LAB38 citations92
US5989827ANov 23, 1999
Use of nuclear magnetic resonance to design ligands to target biomolecules
ABBOTT LAB44 citations92
US7754886B2Jul 13, 2010
N-acylsulfonamide apoptosis promoters
ABBOTT LAB34 citations90
US5665777ASep 9, 1997
Biphenyl hydroxamate inhibitors of matrix metalloproteinases
ABBOTT LAB24 citations90
US6288261B1Sep 11, 2001
Inhibitors of matrix metalloproteinases
ABBOTT LAB10 citations71
US6897337B2May 24, 2005
Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
ABBOTT LAB6 citations63
US7226992B1Jun 5, 2007
Mutant Bcl-2 proteins and uses thereof
ABBOTT LAB0 citations50